Uloric
NDC Package 21695-516-30
Package Information
Uloric is febuxostat is used to lower uric acid levels in people with gout. Marketed by Rebel Distributors Corp, this product is identified by NDC 21695-516 and is authorized under FDA application NDA021856.
Identification & Billing
- RxCUI: 834241 - febuxostat 80 MG Oral Tablet
- RxCUI: 834243 - Uloric 80 MG Oral Tablet
- RxCUI: 834243 - febuxostat 80 MG Oral Tablet [Uloric]
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 21695 - Rebel Distributors Corp
- 21695-516 - Uloric
- 21695-516-30 - 30 TABLET in 1 BOTTLE
- 21695-516 - Uloric
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 21695-516-30 identifies a specific commercial package of 30 tablet in 1 bottle of Uloric, labeled by Rebel Distributors Corp. This product is billed for "EA" each discreet unit and contains an estimated amount of 30 billable units per package. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Rebel Distributors Corp on February 13, 2009. The current certification is valid through December 31, 2017.
What are the primary indications for this medication?
Febuxostat is used to lower uric acid levels in people with gout. Febuxostat works by reducing the amount of uric acid made by the body. An increased uric acid level can cause gout. Because of the risk of very serious heart-related problems and stroke with febuxostat (see also Warning section), febuxostat should be used only after treatment with a medication called allopurinol did not work to lower your uric acid level, caused serious side effects, or is not recommended by your doctor. Febuxostat should be used only if you have symptoms caused by a high blood uric acid level.
How is this Rebel Distributors Corp product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 21695051630. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 30 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.